$RDVT

Red Violet, Inc. (RDVT): Results of Operations and Financial Condition

Red Violet, Inc. (RDVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 rdvt-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 red violet Reports Second Quarter 2026 Financial Results Record Revenue of $26.7 Million, an Increase of 23%; Record Cash Flow from Operations of $10.6 Million BOCA RATON, Fla. – August 10, 2026 – Red Violet, Inc. (NASDAQ: RD

Original reporting
Published Aug 11, 2026, 9:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RDVT
Bullish
medium confidence
Mentioned
$RDVT
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RDVTBullishMed
01

Why it matters

Traders can reassess RDVT’s growth and profitability trajectory while also repricing dilution and capital allocation risk from the newly announced underwritten public offering.

02

Market read

Q2 shows record revenue, margins, net income, and operating cash flow, while the company simultaneously disclosed a sizable equity raise intended for working capital and potential acquisitions.

03

What to watch

Customer growth (IDI and FOREWARN users) is highlighted, but the release does not provide forward guidance or segment-level revenue detail, limiting conviction on sustainability.

Relevance 7/10Novelty 8/10Timing: after-hours/filing today, conference call at 4:30 pm ET

Background

This is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting Red Violet’s Q2 2026 financial results and recent business highlights.

Company-level read

Ticker impact

$RDVTBullishMedium confidence
Context

Red Violet reported Q2 2026 results with revenue up 23% to $26.7M, plus record operating cash flow of $10.6M.

Expected impact

Likely near-term volatility: upside from strong profitability and cash flow, offset by dilution risk from the $109M net offering.

Evidence & confidence

The release includes both an earnings-style datapoint (revenue, margins, net income, cash flow) and a concrete capital raise (1,916,667 shares, net proceeds ~$109M) that can pressure per-share metrics even if fundamentals improved.

Market effects

Supports the identity intelligence and analytics theme with evidence of customer additions and margin expansion.

No clear regional read-through beyond US-listed small-cap tech.

Limited global impact; primarily company-specific execution and financing.

Counterpoint

The equity offering could cap upside if investors focus on dilution and use of proceeds rather than the quarter’s margin gains.

Key entities

  • Red Violet, Inc.

    NASDAQ-listed identity intelligence and analytics company reporting Q2 2026 results and an underwritten public offering.

  • Derek Dubner

    CEO quoted on demand strength, customer additions, and positioning.

Related articles

$RDVTMedAI 8/10

red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters' Option

Red Violet, Inc. (NASDAQ: RDVT) said it closed an underwritten public offering of 1,916,667 shares of common stock, including 250,000 shares from full exercise of the underwriters’ option. The company estimates net proceeds of about $108.6 million. Proceeds will be used for working capital, general corporate purposes, and potential strategic acquisitions.

$RDVTMedAI 8/10

red violet Announces Pricing of $100 Million Underwritten Public Offering of Common Stock

Red Violet, Inc. (NASDAQ: RDVT) priced an underwritten public offering of 1,666,667 shares of common stock at $60.00 per share, raising expected gross proceeds of $100 million before underwriting fees and expenses. The offering is expected to close Aug. 7, 2026, with a 30-day option for up to 250,000 additional shares. Net proceeds will fund working capital and corporate purposes.

$SYKMed

Stryker’s (SYK) Comeback Quarter Looks Great, But At What Cost?

Stryker (NYSE:SYK) reported Q2 results on July 30 with sales up 9.4% to $6.6B and EPS up 44.1% to $3.30. The company cited recovery from a prior cyber incident. It guided full-year organic net sales growth of 8.3% to 9.3% and adjusted EPS of $14.95 to $15.10, while the article highlights a large gap between reported and adjusted earnings.

$BTDRMedAI 8/10

Bitdeer Q2 revenue rises 47% to $228.8 million as net loss widens

Bitdeer (NASDAQ: BTDR) reported Q2 revenue of $228.8 million, up 47.1% year over year. Net loss widened to $92.3 million. Gross loss was $8.5 million with negative 3.7% margin. Adjusted EBITDA rose to $31.1 million. Cash used in operations was $158.5 million and capex was $266 million. The company also reported higher bitcoin mining and AI Cloud revenue.

$MSFTMedAI 8/10

Hedge Funds Favor Microsoft Corporation (MSFT) Over Meta Platforms Inc. (META)

Microsoft (MSFT) shares jumped up to 16% after earnings, adding about $450 billion in market value and lifting its market cap to about $3.35T. The company reported revenue of $90.01B (+18%), adjusted EPS $4.74 vs $4.24 expected, and Azure growth of 43%. Meta (META) fell for an 11th straight day after guidance missed and free cash flow dropped 91% YoY.